In a major healthcare announcement, Donald Trump unveiled TrumpRx.gov, a new federal website aimed at delivering deep discounts on prescription medications for Americans. The initiative, announced during a live event, is positioned as one of the most aggressive efforts yet to lower drug prices in the United States.
Trump said that for decades, American consumers paid the highest prices in the world for medicines while politicians failed to act. According to the administration, TrumpRx.gov represents the largest reduction in prescription drug costs in U.S. history.
Ending America’s Role as the World’s Drug Subsidy
A central theme of the announcement was global price inequality. Trump argued that Americans have long subsidized lower drug prices in other countries. Under the new policy, the U.S. will pay no more than the lowest price paid by any other nation for the same medication.
This “most favored nation” pricing model, achieved through tariff leverage, is expected to rebalance global drug markets. Trump acknowledged that prices abroad may rise as a result, but said the priority is protecting American patients.
Massive Price Cuts on Popular Medications
The administration highlighted dramatic price reductions across several high-demand drug categories:
- Weight-loss & diabetes drugs (GLP-1s)
- Novo Nordisk’s Ozempic: over $1,000 → $199
- Wegovy: over $1,300 → $199
- Insulin
- Eli Lilly’s leading insulin: $200 → $25
- Inhalers
- AstraZeneca’s common inhaler: $458 → $51
- IVF & fertility drugs
- EMD Serono’s Gonal-F: from the highest price in the developed world to the lowest
Officials said dozens of widely used medications are available at launch, with more to follow.
How TrumpRx.gov Works
During the event, Dr. Mehmet Oz and Joe Gebbia, co-founder of Airbnb, demonstrated how Americans can use TrumpRx.gov to:
- Search for discounted prescription drugs
- Compare prices
- Download coupons instantly
- Access “most favored nation” pricing without complex paperwork
The site is designed to be simple and consumer-friendly, particularly for seniors and families managing chronic conditions.
Broad Industry Participation and Long-Term Savings
According to the administration, 16 of the 17 largest pharmaceutical companies have already agreed to offer most-favored-nation prices on all new medicines. Officials estimate the policy could save Americans billions of dollars annually, while making healthcare more affordable across income levels.
Bringing Drug Manufacturing Back to America
Beyond price cuts, Trump said pharmaceutical companies will invest hundreds of billions of dollars to bring drug manufacturing back to the U.S. Tariffs and pricing incentives are expected to accelerate domestic production, creating jobs, strengthening supply chains, and boosting national security.
A Personal Story Behind the Policy
The event also featured emotional testimony from a military spouse who shared her five-year infertility and IVF journey. She described how high fertility drug costs delayed her ability to start a family — and how TrumpRx.gov has already made a meaningful difference for families like hers.
“America First” on Healthcare Costs
Closing the announcement, Trump emphasized that the U.S. is “tired of subsidizing the world” and must put American patients first. He said TrumpRx.gov marks a turning point in healthcare affordability, promising long-term relief for families struggling with rising prescription costs.
Bottom line: TrumpRx.gov positions itself as a sweeping reform of the U.S. drug pricing system — combining global price matching, industry agreements, and domestic manufacturing incentives to dramatically lower costs for American consumers.